featured news

Potential Dangers Lurking in Generic Drugs Manufactured in India

Over the next two posts, we’ll explore a growing international problem involving the safety of generic drugs produced overseas. Namely, generic medications produced in India – including those manufactured by False Claims Act offender Ranbaxy – are becoming more and more problematic, due in part to the alleged falsification of […]

Quest Diagnostics to Pay $1.79 Million to Settle Fraud Claims

Under the guidelines of Medicare Part B, enrollees are entitled to coverage for medically necessary and essential diagnostic services, including bloodwork, x-rays, and similar imaging examinations. If a provider fails to adhere to the Medicare guidelines, it could quickly face liability under the False Claims Act for unlawfully billing the […]

New York Attorney General Announces $8 Million Settlement Over Unlicensed Detox Programs

Following a lengthy investigation by both the state of New York’s Medicaid Fraud Control Unit and the U.S. Attorney’s Office for the Eastern District of New York, several medical corporations operating in the state have agreed to pay $8 million to settle allegations of fraud against Medicaid and Medicare. The […]

Nuances of Liability: Conditions of Payment vs. Conditions of Participation Under the False Claims Act

In yesterday’s post, we reviewed two concepts that often serve as the basis of a whistleblower’s complaint under the False Claims Act. The first is known as a condition of payment violation, which occurs when a provider knowingly submits a claim for reimbursement to Medicare or Medicaid in violation of […]

Understanding Conditions of Payment vs. Conditions of Participation

The False Claims Act is a unique and nuanced law that has been in effect since the 1800s. Since then, it has undergone several amendments and become an integral part of the government’s fight against wasteful healthcare and defense fraud. One of the most highly-contested issues within False Claims Act […]